Literature DB >> 31487215

Outbreak of measles among persons with secondary vaccine failure, China, 2018.

Zhujiazi Zhang1, Meng Chen1, Rui Ma1, Jingbin Pan1, Luodan Suo1, Li Lu1.   

Abstract

Although the incidence of measles has been dramatically reduced by the highly effective measles vaccine, cases of measles and outbreaks continue to occur in vaccinated population because of immunization failure. We report on an outbreak in which two cases had previous evidence of measles immunity and then one of them transmitted measles infection to an unvaccinated contact. The cases and contacts exposed during the outbreak were investigated. Clinical information and epidemiological information were obtained. Serum samples were collected for measles-specific immunoglobulin M (IgM), immunoglobulin G (IgG) and IgG avidity. Throat swabs were obtained to test for measles virus RNA. Two measles cases (case 1 and case 2) who have received one dose of MCV in past 5 years, and both working at a hospital in Beijing, occurred in 18th and 20nd of January, respectively. Out of the 102 contacts, one additional case (case 3) who had a close, long-term co-exposure with case 1 was reported subsequently. No additional cases of measles occurred among 15 contacts of case 3. The index case was not ascertained through the outbreak review. All three cases had laboratory confirmation of measles infection. Both case 1 and case 2 had high-avidity IgG antibody characteristic of a secondary immune response and developed a modified clinical presentation. This report confirms that a vaccinated individual with documented secondary vaccine failure (SVF) could transmit measles and is the second report since a New York City outbreak (the first report in China). The outbreak represented a series of rare events, so we can conclude that the SVF individuals in the transmission chain of measles are unlikely to threaten measles elimination. The importance of the herd immunity in preventing transmission and sensitive surveillance activities in case of misdiagnosis is emphasized.

Entities:  

Keywords:  Measles; outbreak; secondary immunization failure; vaccine failure

Year:  2019        PMID: 31487215      PMCID: PMC7062416          DOI: 10.1080/21645515.2019.1653742

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  29 in total

1.  Vaccine-modified measles in previously immunized children in Accra, Ghana: clinical, virological and serological parameters.

Authors:  N Ishiwada; M M Addae; J K Tetteh; S M Yempewu; D Ofori-Adjei; H Kamiya; B D Akanmori
Journal:  Trop Med Int Health       Date:  2001-09       Impact factor: 2.622

2.  Measles virus nomenclature update: 2012.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-03-02

3.  Measles antibody: reevaluation of protective titers.

Authors:  R T Chen; L E Markowitz; P Albrecht; J A Stewart; L M Mofenson; S R Preblud; W A Orenstein
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

4.  Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.

Authors:  M B Edmonson; D G Addiss; J T McPherson; J L Berg; S R Circo; J P Davis
Journal:  JAMA       Date:  1990-05-09       Impact factor: 56.272

5.  Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness.

Authors:  Inga Velicko; Luise Ledet Müller; Richard Pebody; Bernadette Gergonne; Chinara Aidyralieva; Nina Kostiuchenko; John S Spika
Journal:  Vaccine       Date:  2008-09-19       Impact factor: 3.641

6.  Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.

Authors:  P W Neumann; J M Weber; A G Jessamine; M V O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

7.  Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission.

Authors:  Jennifer S Rota; Carole J Hickman; Sun Bae Sowers; Paul A Rota; Sara Mercader; William J Bellini
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

8.  Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.

Authors:  Sara Mercader; Philip Garcia; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

9.  Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.

Authors:  Cláudio S Pannuti; Ricardo José Morello; José Cássio de Moraes; Suely Pires Curti; Ana Maria S Afonso; Maria Cláudia Corrêa Camargo; Vanda A U F de Souza
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

10.  Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data.

Authors:  Chao Ma; Lixin Hao; Yan Zhang; Qiru Su; Lance Rodewald; Zhijie An; Wenzhou Yu; Jing Ma; Ning Wen; Huiling Wang; Xiaofeng Liang; Huaqing Wang; Weizhong Yang; Li Li; Huiming Luo
Journal:  Bull World Health Organ       Date:  2014-02-05       Impact factor: 9.408

View more
  3 in total

1.  Immunogenicity after outbreak response immunization activities among young healthcare workers with secondary vaccine failure during the measles epidemic in Korea, 2019.

Authors:  Hyeri Seok; Erica Españo; Jooyun Kim; Ji Hoon Jeon; Won Suk Choi; Yun-Kyung Kim; Jeong-Ki Kim; Dae Won Park
Journal:  BMC Infect Dis       Date:  2022-06-08       Impact factor: 3.667

2.  Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018.

Authors:  Aye Mya Chan Thar; Khin Thet Wai; Anthony D Harries; Kyaw Lwin Show; Lei Lei Mon; Htar Htar Lin
Journal:  Trop Med Health       Date:  2020-02-07

3.  Measles in Vaccinated People: Epidemiology and Challenges in Surveillance and Diagnosis in the Post-Elimination Phase. Spain, 2014-2020.

Authors:  Noemí López-Perea; Aurora Fernández-García; Juan Emilio Echevarría; Fernando de Ory; Mayte Pérez-Olmeda; Josefa Masa-Calles
Journal:  Viruses       Date:  2021-10-02       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.